John Koo

Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.

Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine.

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.

Vitamin D and scalp psoriasis.

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.

Quality of life issues in psoriasis.

Traditional Chinese medicine in dermatology.

Case studies in severe psoriasis: A clinical strategy.

Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials.

The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.

Psychocutaneous drug therapy.

How do you foster medication adherence for better acne vulgaris management?

Combination therapy to treat moderate to severe psoriasis.

Psoriasis.

Non-psychotic uses for anti-psychotics.

Narrow-band ultraviolet B radiation: a review of the current literature.

Quality-of-life issues in psoriasis.

Pimozide in dermatologic practice: a comprehensive review.

Definitions of measures of effect duration for psoriasis treatments.

Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use.

Update on the mechanisms and efficacy of biological therapies for psoriasis.

UVB phototherapy and skin cancer risk: a review of the literature.

Smoking and psoriasis.

Rosacea, light, and phototherapy.

Decision points for the initiation of systemic treatment for psoriasis.

Involving the patient: impact of inflammatory skin disease and patient-focused care.

A review of the chemopreventive and chemotherapeutic effects of topical and oral retinoids for both cutaneous and internal neoplasms.

Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.

A review of acitretin, a systemic retinoid for the treatment of psoriasis.

Psychopharmacologic therapies in dermatology: an update.

Alcohol as a risk factor for plaque-type psoriasis.

TNF-alpha inhibitors and congestive heart failure.

Psyche, opioids, and itch: therapeutic consequences.

Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects.

Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy.

Rebound of psoriasis during treatment with efalizumab.

Safety update on commonly used psychotropic medications in dermatology.

The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis.

Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients.

Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter study.

A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.

Morgellons disease: a rapport-enhancing term for delusions of parasitosis.

Predictive value of phenotypic variables for skin cancer: risk assessment beyond skin typing.

Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.

Using topical multimodal strategies for patients with psoriasis.

An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options.

Unraveling the paradoxes of HIV-associated psoriasis: a review of T-cell subsets and cytokine profiles.

"Unknown Risks" of non-steroid topical medications for atopic dermatitis.

Excimer laser for psoriasis: a review of theories regarding enhanced efficacy over traditional UVB phototherapy.

Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine.

Relevance of the COBRA trial in current psoriasis practice.

Treatment of psychocutaneous diseases.

Morgellons disease?

Trichotillomania.

Understanding the psychology of the cosmetic patients.

The psychosocial and occupational impact of chronic skin disease.

Psychopharmacology in dermatology.

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.

An updated review of acitretin--a systemic retinoid for the treatment of psoriasis.

Long-term safety of mycophenolate mofetil and cyclosporine: a review.

A practical review and update on the management of pruritus sine materia.

Cooperative robot assistant for retinal microsurgery.

Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.

Occlusive therapy in atopic dermatitis: overview.

Efalizumab discontinuation: a practical strategy.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

Practice of phototherapy in the treatment of moderate-to-severe psoriasis.

Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis.

Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.

Broadband UVB revisited: is the narrowband UVB fad limiting our therapeutic options?

Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.

Narrowband ultraviolet B phototherapy influences serum folate levels in patients with vitiligo.

Psoriasis: depression, anxiety, smoking, and drinking habits.

Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case series.

Phototherapy in pediatric patients: choosing the appropriate treatment option.

A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: a case report and literature review.

Optimizing topical therapies for treating psoriasis: a consensus conference.

Aripiprazole as a viable alternative for treating delusions of parasitosis.

Efficacy of clobetasol spray: factors beyond patient compliance.

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

Etanercept in the treatment of plaque psoriasis.

Depression and acitretin: a true association or a class labeling?

Introducing the delayed retinoid burn: a case report and discussion of this potential risk of retinoid-phototherapy combination management.

Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? A case report and review of the literature.

Why are there significant differences in published narrowband ultraviolet B dosimetry recommendations? The need for national standardization of phototherapy treatment.

Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy.

Instant barrier repair: A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis.

Yin-yang strategy: proposing a new, effective, repeatable, sequential therapy for psoriasis.

The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know.

Practice gaps. Time and effort to establish therapeutic rapport with delusional patients: comment on "Delusional infestation, including delusions of parasitosis".

Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.

Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial.

A review of the chemopreventative effects of oral retinoids for internal neoplasms.

Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Oral vitamin D, still a viable treatment option for psoriasis.

An evidence-based review of skin cancer rates on biologic therapies.

Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis.

Long-term prognosis of vitiligo patients on narrowband UVB phototherapy.

Quality-of-life instruments: evaluation of the impact of psoriasis on patients.

Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis.

Dermatogeriatrics: a case for developing a new dermatology subspecialty.

Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.

Effective treatment of etanercept and phototherapy-resistant psoriasis using the excimer laser.

Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study.

Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm.

The safety of systemic treatments that can be used for geriatric psoriasis patients: a review.

Trends in older adult psoriasis outpatient health care practices in the United States.

Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: a case series.

Update on the role of systemic vitamin d in atopic dermatitis.

A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions.

Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatrist.

Primary psychiatric conditions: dermatitis artefacta, trichotillomania and neurotic excoriations.

Delusions of parasitosis.

Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy.

The impact of emollients on phototherapy: a review.

A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.

Delusional infestations: clinical presentation, diagnosis and treatment.